E
RPID icon

Ergoteles’s Rapid Micro Biosystems RPID Stock Holding History

Ergoteles’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,624
Closed -$17.8K – 1445
2023
Q1 		$17.8K Sell
13,624
-16,950
-55% -$22K ﹤0.01% 1162
2022
Q4 		$34.5K Sell
30,574
-38,859
-56% -$94.1K ﹤0.01% 1323
2022
Q3 		$224K Sell
69,433
-967
-1% -$3.75K 0.01% 1119
2022
Q2 		$303K Buy
+70,400
New +$328K 0.01% 1099

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Ergoteles's RPID Position: Q2 2023 in Review

Ergoteles sold out of Rapid Micro Biosystems (RPID) in Q2 2023, closing a stake of 13,624 shares — an estimated $17.8K sold.

Ergoteles first reported a position in RPID in Q2 2022 and held it in 4 quarters. The position peaked at $303K in Q2 2022. 24 funds tracked by Wall St. Rank hold RPID as of Q2 2023.

  • Ergoteles reported no remaining Rapid Micro Biosystems position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 13,624 Rapid Micro Biosystems shares in Q2 2023, an estimated $17.8K.
  • Ergoteles first reported a position in Rapid Micro Biosystems in Q2 2022 and held it in 4 quarters.
  • Ergoteles's Rapid Micro Biosystems position peaked at $303K in Q2 2022.
  • 24 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.